Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
South Korea · Delayed Price · Currency is KRW 54,500
+3,000 (5.83%)
Jul 21, 2026, 2:25 PM KST
Mezzion Pharma Market Cap
Mezzion Pharma has a market cap or net worth of 1.58 trillion as of July 20, 2026. Its market cap has increased by 32.51% in one year.
Market Cap
1.58T
Enterprise Value
1.57T
Revenue
7.97B
Ranking
n/a
PE Ratio
n/a
Stock Price
54,500.00
ChartMarket Cap Chart
Since January 20, 2012, Mezzion Pharma's market cap has increased from 240.02B to 1.58T, an increase of 556.69%. That is a compound annual growth rate of 13.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 1.58T | -42.39% |
| Dec 30, 2025 | 2.74T | 195.96% |
| Dec 30, 2024 | 924.37B | -19.89% |
| Dec 28, 2023 | 1.15T | 231.92% |
| Dec 29, 2022 | 347.65B | -82.01% |
| Dec 30, 2021 | 1.93T | 23.60% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.62T |
| Celltrion | 40.32T |
| ALTEOGEN | 14.81T |
| Samsung Epis Holdings | 9.85T |
| Hanmi Science | 2.21T |
| L&C BIO Co.,LTD | 1.91T |
| Celltrion Pharm | 1.76T |
| Daewoong Pharmaceutical | 1.40T |